Loading...
XSTO
ARCOMA
Market cap13mUSD
Jun 02, Last price  
9.76SEK
1D
-1.81%
1Q
-5.70%
Jan 2017
158.89%
IPO
-16.37%
Name

Arcoma AB

Chart & Performance

D1W1MN
P/E
11.51
P/S
0.82
EPS
0.85
Div Yield, %
—
Shrs. gr., 5y
0.84%
Rev. gr., 5y
3.24%
Revenues
157m
-3.81%
147,661,334101,312,157130,434,000123,285,000102,081,00091,848,000119,470,000133,672,000117,417,000117,130,000125,046,000163,015,000156,807,000
Net income
11m
+336.00%
-3,226,662-11,624,161914,000-6,449,000-11,646,000-9,820,000-1,586,0006,610,0001,365,000-7,473,0001,902,0002,564,00011,179,000
CFO
19m
-1.64%
-10,267,844-11,822,783-828,000-4,948,000-4,666,000-8,910,00045,00011,100,0006,846,000-1,932,000-179,00019,160,00018,845,000
Earnings
Aug 13, 2025

Profile

Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
URL
https://www.arcoma.se/
IPO date
Nov 14, 2014
Employees
32
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
156,807
-3.81%
163,015
30.36%
125,046
6.76%
Cost of revenue
94,198
111,601
96,732
Unusual Expense (Income)
NOPBT
62,609
51,414
28,314
NOPBT Margin
39.93%
31.54%
22.64%
Operating Taxes
2,589
570
219
Tax Rate
4.14%
1.11%
0.77%
NOPAT
60,020
50,844
28,095
Net income
11,179
336.00%
2,564
34.81%
1,902
-125.45%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,164
BB yield
-1.16%
Debt
Debt current
1,946
21,219
Long-term debt
2,014
3,986
Deferred revenue
Other long-term liabilities
175
192
Net debt
(13,376)
(1,519)
15,067
Cash flow
Cash from operating activities
18,845
19,160
(179)
CAPEX
(6,781)
(4,169)
Cash from investing activities
(6,781)
(2,553)
(4,169)
Cash from financing activities
(3,874)
(21,219)
9,646
FCF
57,792
58,787
20,424
Balance
Cash
13,376
5,001
9,660
Long term investments
478
478
Excess cash
5,536
3,886
Stockholders' equity
26,371
44,912
42,130
Invested Capital
53,798
52,705
67,273
ROIC
112.71%
84.76%
43.79%
ROCE
105.52%
97.55%
39.79%
EV
Common stock shares outstanding
13,186
13,321
13,064
Price
10.75
35.22%
7.95
3.52%
7.68
-40.92%
Market cap
141,745
33.85%
105,898
5.55%
100,333
-40.37%
EV
128,369
104,379
115,400
EBITDA
70,545
53,003
34,911
EV/EBITDA
1.82
1.97
3.31
Interest
260
1,392
902
Interest/NOPBT
0.42%
2.71%
3.19%